Shanghai, China · Founded 2018 · Privately Held (backing)
Developer of recombinant protein drug intended for synthetic biology. Ruoyi Bio is based in Shanghai, China and was founded in 2018. Its last reported valuation was $23.4 million in Mar 2022. It has raised $7.6 million.
Last reported valuation
$23.4M
Oct 2026
Priced at
—
Total raised
$7.6M
Last round
—
Cap table — not yet on record
Ruoyi Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ruoyi Bio with a free account
·Watch Ruoyi Bio: the Monday email on marks, rounds and moves
